Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

New anticonvulsants from Howard University

Jan. 21, 1997

BMS antidepressant chosen for important multiinstitutional trial

Jan. 20, 1997

Phase II trials begin on ICOS MS treatment

Jan. 20, 1997

Conclusion of Cephalon/Schering-Plough AD collaboration

Jan. 17, 1997

Novel antioxidant disclosed by Nippon Chemiphar

Jan. 17, 1997

Japanese investigators isolate novel aminopeptidase inhibitor

Jan. 17, 1997

New dopamine receptor ligands reported by Roche

Jan. 17, 1997

Avonex update presented

Jan. 16, 1997

Fujisawa characterizes novel antidementia agent

Jan. 16, 1997

Neuroprotective agent described by Taisho

Jan. 16, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...